1 drug(s) with this reaction
2,103 total reports
White Blood Cell Count Decreased has been reported as an adverse reaction across 1 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,103 adverse event reports mention white blood cell count decreased in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with white blood cell count decreased, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have white blood cell count decreased listed in their FDA adverse event reports, sorted by report count:
In addition to white blood cell count decreased, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
1 drug(s) manufactured by Abbvie Inc have white blood cell count decreased listed in their FDA adverse event reports: VENETOCLAX.
There are a combined 2,103 reports of white blood cell count decreased across 1 Abbvie Inc drug(s) in the FDA adverse event database.